National Pharmaceutical Pricing Authority
03 Jun 2018
The government is considering a new method to regulate prices of all medicines sold in India. Currently, only about 17% of the market and 24% of medicines sold in the country is under direct government control.
16 Dec 2017
National Pharmaceutical Pricing Authority's probe into the death of 7-year-old dengue patient, Adya Singh at Gurugram's Fortis Memorial Research Institute revealed her parents were "grossly overcharged".
18 Aug 2017
After capping prices of stents and knee implants, the government is now planning to restrict trade margins to make drugs cheaper and boost the local industry.
17 Aug 2017
The government has slashed prices of knee implants by up to 70%. Price of the widely-used cobalt chromium has come down from Rs. 1,58,324 to Rs. 54,720.
10 Aug 2017
To make knee implants cheaper, the National Pharmaceutical Pricing Authority (NPPA) is now looking at possible capping of prices.
26 Jun 2017
Even after regulation of stents' prices exposed a nexus between industry players (hospitals and sellers) in overcharging people, no action has been taken against anyone.
26 May 2017
The National Pharmaceutical Pricing Authority (NPPA) put a price cap on 31 common drugs like glucose, morphine, paracetamol, ibuprofen and snake venom antiserum.
15 May 2017
Even as stent manufacturers claim huge losses due to recent price controls, shocking statistics tell another tale: apparently, stents in India were among the most expensive, more than US, UK, Germany and Italy.
20 Mar 2017
The health ministry has proposed setting up of an e-portal to regulate the sale of drugs, which aims to make the whole process more transparent.
07 Mar 2017
National Pharmaceutical Pricing Authority has slashed prices of some cancer drugs by upto 86%.
12 Nov 2016
The National Pharmaceutical Pricing Authority (NPPA) the drug price regulator in India slashed prices of drugs used to treat diabetes, cancer, asthma and other common ailments.
22 Oct 2016
The SC ruled on multiple central government notifications that were issued to cap retail prices of drug formulations.
